When was Wanbury Limited founded?

Wanbury Limited was founded in 1990.

Where is Wanbury Limited located?

Wanbury Limited is headquartered in Mumbai, India. It is registered at BSEL Tech Park, 'B; Wing, 10th Floor, Sector 30a, Opp.Vashi Railway Station, V, ashi, New Mumbai, Maharashtra, India, 400703.

How many employees does Wanbury Limited have?

As of Sep 30, 2026, the latest employee count at Wanbury Limited is 1245.

What is the annual revenue of Wanbury Limited?

Annual revenue of Wanbury Limited is between ₹500 Cr and ₹1,000 Cr as on Mar 31, 2025

Where does Wanbury Limited rank among its competitors?

Wanbury Limited ranks 6th amongst 384 active competitors, of which 15 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Almac Group, which secured $417K in Sep, 2022.

Who are the top competitors of Wanbury Limited?

Wanbury Limited's top competitors include Concord Biotech, Biophore and Almac Group. Among them, Almac Group secured the most recent funding round in September, 2022.

Wanbury Limited - 2026 Company Profile, Team, Competitors & Financials

Company Details

Manufacturer of anti-diabetic drugs. It have a significant presence in the pharmaceutical industry, particularly in the production of active pharmaceutical ingredients. Metformin works by improving the body's response to insulin, lowering blood sugar levels, and reducing the amount of glucose absorbed from food and produced by the liver.

Website: wanbury.com
Registered Address: BSEL Tech Park, 'B; Wing, 10th Floor, Sector 30a, Opp.Vashi Railway Station, V, ashi, New Mumbai, Maharashtra, India, 400703

Key Metrics

Founded Year

1990

Location

Mumbai, India

Stage

Public

Ranked

6^th among 384 active competitors

Annual Revenue

₹500 - ₹1,000 Cr as on Mar 31, 2025

Employee Count

1,245 as on Sep 30, 2026

Similar Companies

Concord Biotech & 429 more

Exit Details

Public

View Wanbury Limited's full profile

Wanbury Limited is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
WANBURY PHARMA LIMITED CIN: U33119MH2012PLC237381 , India, Active	Oct 31, 2012	0 - ₹10 Cr (As on Mar 31, 2025)	-
WANBURY LIMITED CIN: L51900MH1988PLC048455 , India, Active	Aug 11, 1988	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	1199 (As on Nov 30, 2024)

Wanbury Limited got listed on Jul 01, 2002.

Click here to take a look at Wanbury Limited's IPO in detail

Wanbury Limited has not raised any funding rounds yet.

The founders of Wanbury Limited is Sanjay Singh.

Here are the details of Wanbury Limited's key team members:

Sanjay Singh: Owner of Wanbury Limited.

View details of Wanbury Limited's Founder profiles and Board Members

Wanbury Limited's employee count trend

Wanbury Limited has 1,245 employees as of Sep 26. Here is Wanbury Limited's employee count trend over the years:

Employee count trend for Wanbury Limited

Uncover Wanbury Limited's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Wanbury Limited include Concord Biotech, Biophore and Almac Group. Here is the list of Top 10 competitors of Wanbury Limited, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Concord Biotech 1984, Ahmedabad (India), Public	CDMO focused on manufacturing API	$11.3M	Quadria Capital, Helix Investments & 18 others	69/100
2nd	Biophore 2007, Hyderabad (India), Seed	Development and manufacturing of niche pharmaceutical products for the generic industry	$2.74M	Ontario & 6 others	62/100
3rd	Almac Group 2001, Craigavon (United Kingdom), Series D	CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development	$339M	Genomic Health, Gates & 4 others	57/100
4th	Indoco Remedies 1947, Mumbai (India), Public	Provider of APIs manufacturing and formulation services	-	Baring Private Equity Partners	54/100
5th	Jagsonpal 1964, Delhi (India), Public	Traditional company manufacturing bulk drugs and finished formulations	-	Convergent, Aresko	53/100
6th	Wanbury Limited 1990, Mumbai (India), Public	Manufacturer of anti-diabetic drugs	-	-	55/100
7th	Galenicum 2003, Barcelona (Spain), Late Stage	Turnkey solutions for drug development, manufacturing and regulatory approvals	-	Peninsula Capital	52/100
8th	Amino 1958, Frellstedt (Germany), Unfunded	CDMO focused on amino acids and small molecules	-	-	51/100
9th	Aizant 2005, Hyderabad (India), Series A	Company offering contract development services for small molecules	$7.59M	Zephyr Management, Zephyr Peacock & 39 others	50/100
10th	Asymchem 1995, Morrisville (United States), Public	CDMO providing comprehensive pharmaceutical development and manufacturing solutions globally	-	Hillhouse, CoStone Capital & 5 others	50/100